RaySearch Laboratories publ : Belgium’s first proton therapy center selects RayStation

Belgium's first proton therapy center has selected the RayStation® treatment planning system. The facility will be equipped with ProteusOne, IBA's compact single-room proton therapy solution, and is expected to open in 2018. The new center is a joint project involving Universitaire Ziekenhuizen Leuven (UZ Leuven), Université Catholique de Louvain (UCL), Katholieke Universiteit Leuven (KU Leuven), Cliniques universitaires Saint-Luc and several other Belgian university hospitals.

RayStation will be the main treatment planning system for proton therapy at UZ Leuven and UCL Saint-Luc, and the system will be in clinical use for proton therapy by 2018.

Prof. Dr. Karin Haustermans, head of the department of radiation therapy oncology at UZ Leuven, says: 'This unique partnership between leading hospitals and universities brings the benefits of proton therapy to Belgium and puts us on the map as a pioneer of advanced techniques. RayStation is key to getting the most from our equipment and achieving our goal of efficient, patient-centered treatment for all cancer patients.'

Johan Löf, CEO of RaySearch, says: 'The choice of ProteusOne together with RayStation creates a perfect match due to the strategic partnership between IBA and RaySearch. This powerful combination will enable highly efficient workflows at the proton therapy center of UZ Leuven and UCL Saint-Luc, with the flexibility to support a diverse range of advanced treatment techniques and machines. We share the partners' vision of unified, personalized patient care, and we are proud to be part of this pioneering collaboration.'